We are live on
!
Find out more
NICM
Neo Ivy Capital Management Portfolio holdings
AUM
$379M
1-Year Est. Return
28.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow
% of AUM
97%
Top 10 Holdings %
Top 10 Hldgs %
17.3%
Holding
278
New
278
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$3.89M |
| 2 |
AT&T
T
|
+$3.66M |
| 3 |
CVS Health
CVS
|
+$3.54M |
| 4 |
Accenture
ACN
|
+$3.24M |
| 5 |
Salesforce
CRM
|
+$3.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Healthcare | 17.6% |
| 3 | Industrials | 10.85% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Financials | 9.79% |
Similar funds
KFS
EAM
MC
ACA
AFCM
DAL
SFWC
WAM
Neo Ivy Capital Management's Q2 2023 Portfolio in Review
Q2 2023 is the first quarter with a 13F filing on record for Neo Ivy Capital Management, which disclosed 278 positions worth $190M. Its ten largest holdings account for 17% of the portfolio.
Its largest position is Humana: 7,737 shares worth $3.46M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Healthcare and Industrials.
- Neo Ivy Capital Management's largest Q2 2023 buy was Humana: 7,737 shares worth $3.46M.
- Neo Ivy Capital Management's ten largest holdings make up 17% of its $190M portfolio in Q2 2023.
- Neo Ivy Capital Management disclosed 278 positions in Q2 2023, its first 13F filing on record.
Based on Neo Ivy Capital Management's 13F filing for Q2 2023, filed 16 Aug 2023.